Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Titel:
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Auteur:
Knox, J.J. Barrios, C.H. Kim, T.M. Cosgriff, T. Srimuninnimit, V. Pittman, K. Sabbatini, R. Rha, S.Y. Flaig, T.W. Page, R.D. Beck, J.T. Cheung, F. Yadav, S. Patel, P. Geoffrois, L. Niolat, J. Berkowitz, N. Marker, M. Chen, D. Motzer, R.J.